Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of folliculogenesis after intrauterine autologous platelet-rich plasma in poor ovarian responders
IRCT20220510054808N1Phase 2Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- May 2022
- Countries
- 1
01
Overview
Phase 2, single-arm trial of platelet-rich plasma in poor ovarian response (POR), sponsored by Qom University of Medical Sciences. Primary endpoint: Folliculogenesis improvement. Started May 2022; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on IRCT20220510054808N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220510054808N1.